Annual D&A
$666.00 K
-$1.80 M-72.99%
31 March 2022
Summary:
Sio Gene Therapies annual depreciation & amortization is currently $666.00 thousand, with the most recent change of -$1.80 million (-72.99%) on 31 March 2022. During the last 3 years, it has fallen by -$1.80 million (-72.99%).SIOX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$0.00
+$134.00 K+100.00%
31 December 2022
Summary:
Sio Gene Therapies quarterly depreciation & amortization is currently $0.00, with the most recent change of +$134.00 thousand (+100.00%) on 31 December 2022.SIOX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$616.00 K
-$65.00 K-9.54%
31 December 2022
Summary:
Sio Gene Therapies TTM depreciation & amortization is currently $616.00 thousand, with the most recent change of -$65.00 thousand (-9.54%) on 31 December 2022.SIOX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SIOX Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -73.0% | -100.0% | +29.4% |
| 5 y5 years | -72.8% | -100.0% | -77.2% |
SIOX Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -78.5% | -100.0% | -83.7% |
Sio Gene Therapies Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | - | $0.00(-100.0%) | $616.00 K(-9.5%) |
| Sept 2022 | - | -$134.00 K(-149.4%) | $681.00 K(-17.7%) |
| June 2022 | - | $271.00 K(-43.4%) | $827.00 K(+24.2%) |
| Mar 2022 | $666.00 K(-73.0%) | $479.00 K(+636.9%) | $666.00 K(+39.9%) |
| Dec 2021 | - | $65.00 K(+441.7%) | $476.00 K(-54.5%) |
| Sept 2021 | - | $12.00 K(-89.1%) | $1.05 M(-36.8%) |
| June 2021 | - | $110.00 K(-61.9%) | $1.66 M(-32.8%) |
| Mar 2021 | $2.47 M(-20.3%) | $289.00 K(-54.6%) | $2.47 M(-14.8%) |
| Dec 2020 | - | $636.00 K(+2.3%) | $2.89 M(-6.9%) |
| Sept 2020 | - | $622.00 K(-32.3%) | $3.11 M(-3.5%) |
| June 2020 | - | $919.00 K(+28.4%) | $3.22 M(+4.0%) |
| Mar 2020 | $3.09 M(+26.3%) | $716.00 K(-15.7%) | $3.09 M(+14.4%) |
| Dec 2019 | - | $849.00 K(+15.7%) | $2.71 M(+16.0%) |
| Sept 2019 | - | $734.00 K(-7.7%) | $2.33 M(+5.5%) |
| June 2019 | - | $795.00 K(+143.1%) | $2.21 M(-9.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | $2.45 M(-20.5%) | $327.00 K(-31.3%) | $2.45 M(-20.8%) |
| Dec 2018 | - | $476.00 K(-22.3%) | $3.09 M(-16.0%) |
| Sept 2018 | - | $613.00 K(-40.7%) | $3.68 M(-2.7%) |
| June 2018 | - | $1.03 M(+6.6%) | $3.78 M(+22.7%) |
| Mar 2018 | $3.08 M(+1138.2%) | $970.00 K(-8.7%) | $3.08 M(+32.5%) |
| Dec 2017 | - | $1.06 M(+48.7%) | $2.33 M(+82.2%) |
| Sept 2017 | - | $715.00 K(+113.4%) | $1.28 M(+122.9%) |
| June 2017 | - | $335.00 K(+56.5%) | $573.00 K(+130.1%) |
| Mar 2017 | $249.00 K(+1678.6%) | $214.00 K(+1546.2%) | $249.00 K(+507.3%) |
| Dec 2016 | - | $13.00 K(+18.2%) | $41.00 K(+86.4%) |
| Sept 2016 | - | $11.00 K(0.0%) | $22.00 K(-8.3%) |
| June 2016 | - | $11.00 K(+83.3%) | $24.00 K(+71.4%) |
| Mar 2016 | $14.00 K | $6000.00(-200.0%) | $14.00 K(+75.0%) |
| Dec 2015 | - | -$6000.00(-146.2%) | $8000.00(-42.9%) |
| Sept 2015 | - | $13.00 K(+1200.0%) | $14.00 K(+1300.0%) |
| June 2015 | - | $1000.00 | $1000.00 |
FAQ
- What is Sio Gene Therapies annual depreciation & amortization?
- What is the all time high annual D&A for Sio Gene Therapies?
- What is Sio Gene Therapies quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Sio Gene Therapies?
- What is Sio Gene Therapies TTM depreciation & amortization?
- What is the all time high TTM D&A for Sio Gene Therapies?
What is Sio Gene Therapies annual depreciation & amortization?
The current annual D&A of SIOX is $666.00 K
What is the all time high annual D&A for Sio Gene Therapies?
Sio Gene Therapies all-time high annual depreciation & amortization is $3.09 M
What is Sio Gene Therapies quarterly depreciation & amortization?
The current quarterly D&A of SIOX is $0.00
What is the all time high quarterly D&A for Sio Gene Therapies?
Sio Gene Therapies all-time high quarterly depreciation & amortization is $1.06 M
What is Sio Gene Therapies TTM depreciation & amortization?
The current TTM D&A of SIOX is $616.00 K
What is the all time high TTM D&A for Sio Gene Therapies?
Sio Gene Therapies all-time high TTM depreciation & amortization is $3.78 M